Life Science Company News

Invitation to presentation of Sectra's six-month interim report 2023/2024

LINKÖPING, Sweden, Dec. 1, 2023 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's six-month report with President Torbjörn Kronander and CFO Jessica Holmquist.

Publication of the financial report: 8:15 a.m. (CET) on December 15, 2023

Report presentation: 10:00 a.m. (CET) on the same date

To participate, follow the instructions on Sectra's website  The broadcast will be made available on the same webpage after the conference.

Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to

Sectra's financial reporting calendar and Annual General Meeting

  • March 8, 2024:   Nine-month interim report
  • June 5, 2024:   Year-end report

For more information about Sectra's financial events and reports, visit

Subscribe for information

To subscribe for financial reports, invitations and information from Sectra via email, please fill in your contact information at

About Sectra

Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2022/2023 fiscal year totaled SEK 2,351 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website.

For further information, please contact: 

Helena Pettersson, Chief Investor Relations Officer Sectra AB, telephone +46 (0)13 23 52 04, e-mail


Cision View original content:

By: PR Newswire Association LLC. - 01 Dec 2023
Back to overview

Enhance your business development with Biotechgate